Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

September 29, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Advanced MalignanciesNSCLCOvarian CancerUrothelial CancerSolid Tumors
Interventions
DRUG

Avelumab

oral

DRUG

Lorlatanib

oral

DRUG

Talazoparib

oral

DRUG

Pemetrexed

IV (intravenous) infusion

DRUG

Axitinib

oral

DRUG

CMP 001

IT (intratumoral) or SC (subcutaneous)

DRUG

Utomilumab

IV infusion

DRUG

PF04518600

IV infusion

Trial Locations (68)

333

Chang Gung Medical Foundation-Linkou Branch, Taoyuan District

704

National Cheng Kung University Hospital, Tainan City

1023

Auckland City Hospital, Auckland

1122

Országos Onkológiai Intézet, Budapest

2060

Mater Hospital Sydney, Wollstonecraft

2065

Melanoma Institute Australia, Wollstonecraft

2109

Macquarie University, North Ryde

4032

The Prince Charles Hospital, Chermside

6060

Grand Hôpital de Charleroi, Gilly

9000

UZ Gent, Ghent

Aalborg Universitetshospital, Syd, Aalborg

10002

National Taiwan University Hospital, Taipei

10021

Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York

10022

Memorial Sloan Kettering Cancer Center 53rd street., New York

10065

Memorial Sloan Kettering Cancer Center, New York

10408

National Cancer Center, Goyang-si

10604

MSK Westchester, Harrison

11000

Institute for Oncology and Radiology of Serbia, Belgrade

11553

MSK Nassau, Uniondale

11725

MSK Commack, Commack

13620

Seoul National University Bundang Hospital, Seongnam

19104

Hospital of the University of Pennsylvania, Philadelphia

20089

IRCCS Istituto Clinico Humanitas, Rozzano

20133

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

21565

Gachon University Gil Medical Center, Namdong-gu

28040

Hospital Universitario Fundación Jiménez Díaz, Madrid

28050

Hospital Universitario HM Sanchinarro, Madrid

33612

Moffitt Cancer Center, Tampa

41014

Hospital Universitario Virgen de Valme, Seville

54519

Institut de Cancérologie de Lorraine Alexis Vautrin, Vandœuvre-lès-Nancy

60126

Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi, Ancona

64460

"Hospital Universitario Dr. Jose Eleuterio Gonzalez", Monterrey

68000

Oaxaca Site Management Organization S.C., Oaxaca City

72703

Highlands Oncology Group, PA, Fayetteville

72758

Highlands Oncology Group, PA, Rogers

72762

Highlands Oncology Group, PA, Springdale

77030

The University of Texas MD Anderson Cancer Center, Houston

90095

UCLA Hematology/Oncology, Los Angeles

98109

Fred Hutchinson Cancer Center, Seattle

125284

Moscow Scientific Research Oncology Institute n.a. P.A. Hertzen, Moscow

196603

"Private Medical Institution Euromedservice", Pushkin

357502

GBUZ SK Pyatigorsk Interdistrict Oncology dispensary, Pyatigorsk

450054

SAHI Republican Clinical Oncology Dispensary under the Ministry of Health, Republic of Bashkortostan, Ufa

603109

"FBIH Privolzhskiy Regional Medical Center of FMBA", Nizhny Novgorod

644013

"Budgetary Healthcare Institution of Omsk Region Clinical Oncology Dispensary", Omsk

4941492

Rabin Medical Center, Petah Tikva

07920

MSK Basking Ridge, Basking Ridge

07748

MSK Monmouth, Middletown

07645

MSK Bergen, Montvale

T6G 1Z2

Cross Cancer Institute, Edmonton

K7L 2V7

Kingston Health Sciences Centre-Kingston General Hospital Site, Kingston

879-5593

Oita University Hospital, Yufu

104-0045

National Cancer Center Hospital, Chuo-ku

135-8550

Japanese Foundation for Cancer Research, Koto

811-1395

National Hospital Organization Kyushu Cancer Center, Fukuoka

02-507

Centralny Szpital Kliniczny MSWiA w Warszawie, Warsaw

02-781

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie, Warsaw

03080

Seoul National University Hospital, Seoul

05505

Asan Medical Center, Seoul

06351

Samsung Medical Center, Seoul

08035

Hospital Universitari Vall d'Hebron, Barcelona

Hospital Universitari Vall d'Hebron, Barcelona

08036

Hospital Clínic de Barcelona, Barcelona

08908

Institut Català d'Oncologia - L'Hospitalet, L'Hospitalet de Llobregat

SW3 6JJ

Royal Marsden Hospital (Chelsea), London

NE7 7DN

The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne

TR1 3LJ

Royal Cornwall Hospitals NHS Trust, Truro

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY